Sharenet Sites 
Sharenet Sites
Summarised audited results for the financial year ended 30 June 2022 and dividend declaration
AfroCentric Investment Corporation Limited
(Incorporated in the Republic of South Africa)
(Registration number 1988/000570/06)
JSE Code: ACT ISIN: ZAE000078416
(“the Company" or AfroCentric”)
Short Form Announcement: Summarised audited results for the financial year ended 30 June 2022
and dividend declaration
Introduction to the AfroCentric Group
AfroCentric is a Level 1, majority black-owned JSE Limited listed investment holding company, which owns
and operates a diverse range of healthcare-related enterprises that provide specialised medical scheme
administration and deliver a range of healthcare products and services to the public and private healthcare
sectors. The principal objective of the Group is to ensure the delivery of efficient health management
services and the distribution of quality products – all at a manageable and affordable cost for the benefit
of our stakeholders. AfroCentric has successfully broadened its interests in the industry by continuing to
pursue new opportunities to expand and rationalise its presence across the healthcare sector
The Board is pleased to present a summary of the Company’s results for the financial year ended 30 June
2022.
Salient Features
% Audited twelve Audited twelve
change months ended months ended
30 June 2022 30 June 2021
Total revenue from contracts with customers (R’ 8 8 722.6 8 074.4
million)
Profit before tax (R’ million) (3.5) 675.2 699.5
Profit for the year (R’ million) 2.6 481.7 469.7
Basic earnings (R’ million) 4.1 314.3 302.0
Headline earnings (R’ million) (3.6) 317.1 329.1
Basic earnings (cents per share) 3.8 54.57 52.56
Headline earnings (cents per share) (3.8) 55.07 57.26
Weighted average number of ordinary shares 575.9 574.7
Dividend declared (cents per share) 0 17 17
Dividends
The Board has pleasure in announcing that a final gross dividend of 17.00000 cents per ordinary share
has been declared for the year ended 30 June 2022. Dividends are subject to Dividends Tax. The payment
date for the dividend is Monday, 14 November 2022.
Dividends have been declared out of profits available for distribution.
Local Dividends Withholding Tax rate is 20%.
The gross dividend amount is 17.00000 cents per ordinary share.
Net cash dividend amount is therefore 13.60000 cents per ordinary share.
The Company has 576 711 257 ordinary shares in issue as at the declaration date.
The Company’s income tax reference number is 9600/148/71/3.
The salient dates relating to the dividend are as follows:
Last day to trade cum dividend Tuesday, 8 November 2022
Shares commence trading ex-dividend Wednesday, 9 November 2022
Dividend record date Friday, 11 November 2022
Dividend payment date Monday, 14 November 2022
Share certificates may not be dematerialised or rematerialised between Wednesday, 9 November 2022
and Friday, 11 November 2022, both days inclusive.
Full Announcement
This short-form announcement is the responsibility of the Directors of the Company and is a summary of the
information in the full announcement and does not contain full or complete details of the full announcement,
which is available for viewing on the following websites:
Company’s website: https://www.afrocentric-online.co.za/inv-reporting.php
JSE website: https://senspdf.jse.co.za/documents/2022/jse/isse/act/act2022.pdf
These financial results were prepared under supervision of the Group Chief Financial Officer, Mr H
Boonzaaier. Although these financial results were themselves not audited, they are extracted from the
consolidated and company annual financial statements which were audited by PricewaterhouseCoopers
Inc, who issued an unmodified audit opinion on the financial statements. Their audit opinion can be viewed
on the Company’s website, which also provides more details on the key audit matters identified, and
appear on pages 13 - 18 of the annual financial statements.
Any investment decision by investors and/or shareholders should be based on consideration of the
information contained in the full financial results announcement and annual financial statements, copies
of which are also available for inspection at the Company’s offices on workdays during business hours (at
no charge) or on request from the company secretary by e-mail: billym@afrocentrichealth.com
On behalf of the Board
Dr ATM Mokgokong Mr A Banderker
Chairperson Group Chief Executive Officer
Johannesburg
13 September 2022
JSE Sponsor to AfroCentric
Questco Corporate Advisory Proprietary Limited
Date: 13-09-2022 12:40:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
